Tremelimumab: as the comparator
1 studies: what is tested is compared with it. Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
1 studies: what is tested is compared with it. Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.